Galderma, a global healthcare company focused on skin health, announced that it has received FDA approval to market Restylane® Lyft for cheek augmentations. It can also be used to correct age-related changes of the face, especially mid-face differences that develop over time, usually beginning at age 21.
It is the first and only FDA approved dermal filler that is capable of providing facial fullness in the mid-facial area such as the cheeks and correct the nasolabial folds, also known as "smile lines."
Although this method of cheek treatment has just been approved, there are other ways plastic surgery patients can achieve their desired appearance.
At Marotta Plastic Surgery Specialists, one of these procedures is known as cheek implants. Unlike injections, cheek implants don't have to be repeated. Although injections are capable of making physical changes, they require routine updates and refills to keep the desired appearance.
Cheekbone implants correct the deficiency of the cheek bone itself. Placed in the most prominent area of the bone, known as the malar prominence, the augmentation gives the patient a higher arched cheek bone and an overall more attractive facial profile. This procedure can also be combined with submalar implants, focusing too on the fleshy portion below the cheek. By filling in this area, youthfulness is restored and a sunken appearance, often associated with aging, is eliminated.
If necessary, additional augmentation of the lower part of the cheek can be made using fillers or fat.
A youthful, full-faced appearance has long been associated with virility and a young age. Reclaim the healthy, full stature of your face with a cheek augmentation today. To learn more about the procedure or determine if it's right for you,visit our website or schedule a consultation with dual board certified facial plastic surgeon Dr. James Marotta today.
